MR MIGHTY trial_Evaluation and optimization of MR-guided microwave ablation (MWA) of liver tumors avoiding ionizing radiation

MR MIGHTY trial_Evaluation and optimization of MR-guided microwave ablation (MWA) of liver tumors avoiding ionizing radiation - MR MIGHTY trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031953

Enrollment

Registered

2024-02-23

Start date

2024-04-04

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22 C78.7

Interventions

Group 1: Patients who meet all inclusion criteria and no exclusion criteria may be proposed for the study and the patient will be informed about the study and the procedure. Inclusion in the study is

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinical indication for local ablative therapy of liver tumors (liver metastases or primary liver tumors). The indication for intervention in this case must be independent of the presented study. No contraindication to MRI examination. Size of the lesion =3cm

Exclusion criteria

Exclusion criteria: Contraindications to MRI examination, especially implants not suitable for MR, tattoos or piercings, limiting claustrophobia.

Design outcomes

Primary

Measure	Time frame
Local control rate during follow-up (12 months)	—

Secondary

Measure	Time frame
Local tumor control rate after MRI-guided MWA. Prospective evaluation of the accuracy of real-time MRI thermometry during microwave ablation to predict the size and geometry of the ablation zone and thus reduce the uncertainty related to the actual ablation zone.	—

Countries

Germany

Contacts

Public ContactMatthias Fabritius

LMU München

Matthias.Fabritius@med.uni-muenchen.de+4989440076642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026